HomeCompareOLYMY vs BTI

OLYMY vs BTI: Dividend Comparison 2026

OLYMY yields 1.49% · BTI yields 5.38%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 OLYMY wins by $19.37M in total portfolio value· pulled ahead in Year 3
10 years
OLYMY
OLYMY
● Live price
1.49%
Share price
$9.37
Annual div
$0.14
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$19.41M
Annual income
$17,198,899.56
Full OLYMY calculator →
BTI
BTI
● Live price
5.38%
Share price
$58.47
Annual div
$3.15
5Y div CAGR
11.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$37.7K
Annual income
$2,786.64
Full BTI calculator →

Portfolio growth — OLYMY vs BTI

📍 OLYMY pulled ahead of the other in Year 3

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodOLYMYBTI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, OLYMY + BTI cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
OLYMY pays
BTI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

OLYMY
Annual income on $10K today (after 15% tax)
$127.00/yr
After 10yr DRIP, annual income (after tax)
$14,619,064.63/yr
BTI
Annual income on $10K today (after 15% tax)
$457.40/yr
After 10yr DRIP, annual income (after tax)
$2,368.64/yr
At 15% tax rate, OLYMY beats the other by $14,616,695.98/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of OLYMY + BTI for your $10,000?

OLYMY: 50%BTI: 50%
100% BTI50/50100% OLYMY
Portfolio after 10yr
$9.72M
Annual income
$8,600,843.10/yr
Blended yield
88.45%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on BTI right now

OLYMY
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
3.3
Piotroski
7/9
BTI
Analyst Ratings
12
Buy
4
Hold
2
Sell
Consensus: Buy
Price Target
$40.00
-31.6% upside vs current
Range: $40.00 — $40.00
Altman Z
2.1
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

OLYMY buys
0
BTI buys
0
No recent congressional trades found for OLYMY or BTI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricOLYMYBTI
Forward yield1.49%5.38%
Annual dividend / share$0.14$3.15
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%11.3%
Portfolio after 10y$19.41M$37.7K
Annual income after 10y$17,198,899.56$2,786.64
Total dividends collected$19.21M$14.3K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusBuyBuy

Year-by-year: OLYMY vs BTI ($10,000, DRIP)

YearOLYMY PortfolioOLYMY Income/yrBTI PortfolioBTI Income/yrGap
1$10,999$298.83$11,299$598.92$300.00BTI
2$12,383$614.34$12,794$703.91$411.00BTI
3← crossover$14,543$1,292.83$14,518$829.07+$25.00OLYMY
4$18,399$2,837.94$16,513$978.64+$1.9KOLYMY
5$26,398$6,711.03$18,827$1,157.84+$7.6KOLYMY
6$46,243$17,997.57$21,518$1,373.12+$24.7KOLYMY
7$108,411$58,930.72$24,657$1,632.46+$83.8KOLYMY
8$374,234$258,234.50$28,329$1,945.74+$345.9KOLYMY
9$2,066,647$1,666,216.42$32,637$2,325.33+$2.03MOLYMY
10$19,410,212$17,198,899.56$37,708$2,786.64+$19.37MOLYMY

OLYMY vs BTI: Complete Analysis 2026

OLYMYStock

Olympus Corporation, together with its subsidiaries, manufactures and sells medical equipment in Japan, America, the Middle East, Asia, and Oceania. It operates through Endoscopic Solutions Business, Therapeutic Solutions Business, and Other segments. The company offers gastrointestinal endoscopy system products comprising video endoscopy and ultrasound systems; GI endotherapy products consisting of CRC devices and HPB devices/hemostasis products; endoscopic solutions ecosystem products, including intelligent ecosystem operating software platforms, and AI insights and computer-aided detection/diagnosis products; reprocessing products, such as endoscope reprocessors, chemicals, accessories, and peripherals; and medical services, which include repair center services. It also provides respiratory products comprising bronchoscopy systems and devices, lung cancer products, and chronic obstructive pulmonary disease products; urology products consisting of visualization, stone management, benign prostatic hyperplasia (BPH), and BPH + bladder cancer products; surgical products, such as surgical endoscopy systems, advanced energy devices, surgical microscope, integrated procedure room solutions, and rhino-laryngoscopy systems, as well as surgical devices for the ears, nose, and throat; and gastroenterology devices and gynecology products. The company was formerly known as Olympus Optical Co., Ltd. and changed its name to Olympus Corporation in October 2003. Olympus Corporation was incorporated in 1919 and is headquartered in Hachioji, Japan.

Full OLYMY Calculator →

BTIConsumer Staples

British American Tobacco p.l.c. provides tobacco and nicotine products to consumers in the Americas, Europe, the Asia-Pacific, the Middle East, Africa, and the United States. It offers vapour, heated, and modern oral nicotine products; combustible cigarettes; and traditional oral products, such as snus and moist snuff. The company provides its products under the Vuse, glo, Velo, Grizzly, Kodiak, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Newport, Natural American Spirit, and Camel brands. The company distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is based in London, the United Kingdom.

Full BTI Calculator →
📬

Get this OLYMY vs BTI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

OLYMY vs SCHDOLYMY vs JEPIOLYMY vs OOLYMY vs KOOLYMY vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.